Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Apr;46(4):427-30.
doi: 10.1111/j.1365-4632.2006.03138.x.

Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts

Joe A Khattar  1 , Umayya M Musharrafieh, Hala Tamim, Ghassan N Hamadeh
Affiliations
Randomized Controlled Trial

Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts

Joe A Khattar et al. Int J Dermatol. 2007 Apr.

Abstract

Background: Warts are a common dermatologic problem. Treatment is painful, prolonged, and can cause scarring.

Objective: To evaluate topical zinc oxide for the treatment of warts.

Methods: This was a randomized, double-blind controlled trial of 44 patients. Twenty-two patients were given topical zinc oxide 20% ointment, and the other 22 received salicylic acid 15% + lactic acid 15% ointment twice daily. All patients were followed up for 3 months or until cure, whichever occurred first. All patients were observed for side-effects.

Results: Sixteen patients in the zinc group and 19 in the salicylic acid-lactic acid group completed the study. In the zinc oxide-treated group, 50% of the patients showed complete cure and 18.7% failed to respond, compared with 42% and 26%, respectively, in the salicylic acid-lactic acid-treated group. No patients developed serious side-effects.

Conclusion: Topical zinc oxide is an efficacious, painless, and safe therapeutic option for wart treatment.

PubMed Disclaimer

Publication types

LinkOut - more resources